CREDIT SUISSE AG/ - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 131 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$9,572,000
+2581.2%
254,090
+1111.9%
0.01%
Q4 2020$357,000
+275.8%
20,966
-14.5%
0.00%
Q3 2019$95,000
-51.3%
24,513
-24.3%
0.00%
Q2 2019$195,000
-44.1%
32,362
+24.7%
0.00%
Q1 2019$349,000
+35.3%
25,956
-6.6%
0.00%
Q4 2018$258,000
-19.6%
27,787
+20.2%
0.00%
Q3 2018$321,000
-51.2%
23,121
-44.5%
0.00%
-100.0%
Q2 2018$658,000
-17.5%
41,629
-10.4%
0.00%0.0%
Q1 2018$798,000
+1.5%
46,439
+29.3%
0.00%0.0%
Q4 2017$786,000
-78.0%
35,913
-58.8%
0.00%
-66.7%
Q3 2017$3,566,000
+32.8%
87,127
-2.3%
0.00%0.0%
Q2 2017$2,685,000
-31.1%
89,171
-17.3%
0.00%
-25.0%
Q1 2017$3,898,000
+2.3%
107,793
+41.7%
0.00%0.0%
Q4 2016$3,811,000
-5.3%
76,053
-0.8%
0.00%0.0%
Q3 2016$4,026,000
+51.3%
76,696
+19.1%
0.00%
+33.3%
Q2 2016$2,661,000
+9.1%
64,371
+7.3%
0.00%0.0%
Q1 2016$2,440,000
+557.7%
60,019
+570.5%
0.00%
Q4 2015$371,000
+78.4%
8,952
-33.8%
0.00%
Q3 2015$208,000
-85.7%
13,524
-76.9%
0.00%
-100.0%
Q2 2015$1,456,000
+56.2%
58,597
+43.7%
0.00%0.0%
Q1 2015$932,000
+81.3%
40,790
+114.3%
0.00%
Q4 2014$514,00019,0370.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BVF INC/IL 3,381,117$47,065,0004.14%
GREAT POINT PARTNERS LLC 1,647,753$22,937,0003.58%
Rock Springs Capital Management LP 598,000$8,324,0000.30%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 136,029$1,894,0000.14%
FOX RUN MANAGEMENT, L.L.C. 20,935$291,0000.13%
Hilltop Holdings Inc. 39,824$554,0000.12%
WEXFORD CAPITAL LP 112,700$1,569,0000.10%
OXFORD ASSET MANAGEMENT LLP 296,339$4,132,0000.09%
Vident Investment Advisory, LLC 133,272$1,855,0000.07%
ALTRINSIC GLOBAL ADVISORS LLC 90,000$1,253,0000.06%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders